Form D · Biotechnology
ProEncia Biotechnology Inc.
Woodbury, MN · CIK 0002103044
Offering snapshot reported Aug 26, 2026 · SEC filing
- Reported sold
- $1.51M Offering amount: $2M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Oct 4, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2026 | Initial | $1,510,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-595503
Source: Form D, filed Aug 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tapos Ghosh | Director, Executive |
| Tarun Ghosh | Director |
| Thomas Hoover | Executive |
| Austin Loeb | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9094 Princeton Road
Woodbury, MN, 55125
Phone: (763) 464-2812
Woodbury, MN, 55125
Phone: (763) 464-2812